Feasibility of ExAblate MRI Guided High Intensity Focused Ultrasound Tx of Soft Tissue Tumors

Trial ID or NCT#

NCT01965002

Status

not recruiting iconNOT RECRUITING

Purpose

The goal of this project is to evaluate the safety and preliminary efficacy of ExAblate magnetic resonance-guided high-intensity focused ultrasound (MRgHIFU) surgery in the treatment of soft tissue tumors of the extremities.

Official Title

A Feasibility Study to Evaluate the Safety and Effectiveness of ExAblate Magnetic Resonance Imaging Guided High Intensity Focused Ultrasound Treatment of Soft Tissue Tumors of the Extremities

Eligibility Criteria

Ages Eligible for Study: Older than 10 Years
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: No
Show Less

Investigator(s)

Raffi S. Avedian, MD
Raffi S. Avedian, MD
Orthopaedic surgical oncologist, Sarcoma specialist, Musculoskeletal tumors surgeon
Associate Professor of Orthopaedic Surgery
Pejman Ghanouni, MD, PhD
Pejman Ghanouni, MD, PhD
Radiologist
Associate Professor of Radiology (General Radiology) and, by courtesy, of Neurosurgery, of Obstetrics and Gynecology and of Urology

Contact us to find out if this trial is right for you.

Contact

ccto-office@stanford.edu
650-498-7061

View on ClinicalTrials.gov